The EHC represents approximately 90,000 people diagnosed with a rare bleeding condition such as haemophilia , von Willebrand Disease (VWD) and other rare bleeding disorders across Europe. However, it is estimated that many more live with an undiagnosed rare bleeding disorder.
The EHC draws on the knowledge of patients, healthcare professionals, the scientific community, the European institutions and the pharmaceutical industry to share expertise within Europe. The EHC also collaborates closely with other European patient organisations to ensure a strong collective voice for people with rare bleeding disorders.
Links to ehc.eu (18)
cor2ed.comIndependent Medical Education for HCPs provided by COR2ED
afh.asso.frAFHAssociation Française Hémophiles & Malades hémorragiques rares - AFH
Independent Medical Education for HCPs provided by COR2ED